US Stock MarketDetailed Quotes

ADCT ADC Therapeutics

Watchlist
  • 2.790
  • -0.140-4.78%
Close Aug 16 16:00 ET
  • 2.790
  • 0.0000.00%
Post 20:01 ET
269.65MMarket Cap-1098P/E (TTM)

ADC Therapeutics Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

ADC Therapeutics Q2 2024 Earnings Date

Currency：USDAug 6, 2024

Estimate
(YoY)		 Actual
(YoY)		 Vs Estimate
(% Chg)
Revenue
18.80M
17.41M
-1.39M
Miss Est.
-2.52%
-9.71%
-7.38%
EPS
-0.46
-0.38
+0.08
Beat Est.
+21.18%
+36.67%
+16.87%
Analyst Rating
Strong Buy

Aug 7, 2024

ADC Therapeutics Earnings Estimates

Revenue

EPS

EBIT

Revenue is based on 7 analyst forecasts. Estimate data is from S&P, and actual data is from Income Statement

Currency: USD

Actual
Estimate
DatePeriodRevenue/EstimateEarnings Call
--2024/Q4-- / 19.104M--
--2024/Q3-- / 18.395M--
Aug 6, 20242024/Q217.410M / 18.798M--
May 6, 20242024/Q118.053M / 18.102M--
Mar 13, 20242023/Q416.790M / 15.260M--
DatePeriodRevenue/EstimateEarnings Call
--2024/Q4-- / 19.104M--
--2024/Q3-- / 18.395M--
Aug 6, 20242024/Q217.410M / 18.798M--
May 6, 20242024/Q118.053M / 18.102M--
Mar 13, 20242023/Q416.790M / 15.260M--

Unlock Free Earnings Estimates

ADC Therapeutics Earnings Reports

  • ADC Therapeutics | 10-Q: Q2 2024 Earnings Report

    Aug 6 10:08 ET

  • ADC Therapeutics | 10-Q: Q1 2024 Earnings Report

    May 6 06:43 ET

  • ADC Therapeutics | 10-K: FY2023 Annual Report

    Mar 13 12:28 ET

  • ADC Therapeutics | 6-K: Report of foreign private issuer (related to financial reporting)

    Nov 7, 2023 07:13 ET

    • Read more

    Analysis

    Analyst Rating

    Updated: Aug 7, 2024

    Strong Buy

    • Buy

      100.00%

    • Hold

      0.00%

    • Sell

      0.00%

    Price Target

    No Data

    Heat List
    US
    Overall
    Symbol
    Latest Price
    % Chg